Centers for Disease Control and Prevention
Atlanta, Georgia, United States
Purpose
to support the lab work related to serum neutralization assays and viral shedding analyses of the samples from clinical trials (comparator trials and phase I and II trials with the investigational vaccine) for the novel Oral Polio Vaccine d
Division
Global Development
Date
May 2016
Region Served
GLOBAL
Committed amount
$1,844,756
Grant topic
Polio
Duration (months)
125
Grantee location
Atlanta, Georgia, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.